UBS Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8K | Buy |
|
|||||
|
2025
Q1 | $2.04K | Buy |
|
|||||
|
2024
Q4 | $145 | Sell |
|
|||||
|
2024
Q3 | $23.5K | Buy |
|
|||||
|
2024
Q2 | $430 | Sell |
|
|||||
|
2024
Q1 | $9.85K | Buy |
|
|||||
|
2023
Q4 | $484 | Sell |
|
|||||
|
2023
Q3 | $32.8K | Buy |
|
|||||
|
2023
Q2 | $39.3K | Sell |
|
|||||
|
2023
Q1 | $60.2K | Sell |
|
|||||
|
2022
Q4 | $79K | Buy |
|
|||||
|
2022
Q3 | $46K | Buy |
|
|||||
|
2022
Q2 | $1K | Hold |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $529K | Buy |
|
|||||
|
2021
Q3 | $530K | Buy |
|
|||||
|
2021
Q2 | $27K | Sell |
|
|||||
|
2021
Q1 | $456K | Buy |
|
|||||
|
2020
Q4 | $278K | Buy |
|
|||||
|
2020
Q3 | $6K | Sell |
|
|||||
|
2020
Q2 | $80K | Sell |
|
|||||
|
2020
Q1 | $73K | Sell |
|
|||||
|
2019
Q4 | $137K | Buy |
|
|||||
|
2019
Q3 | $117K | Sell |
|
|||||
|
2019
Q2 | $136K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $20K | Buy |
|
|||||
|
2018
Q3 | $25K | Buy |
|
|||||
|
2018
Q2 | $13K | Buy |
|
|||||
|
2018
Q1 | $7K | Buy |
|
|||||
|
2017
Q4 | $1K | Buy |
|